Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure

NCT00922532 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company decision not to pursue prior to submission

Conditions

Hypoxic Respiratory Failure With Pulmonary Hypertension

Interventions

DRUG: Inhaled Nitric Oxide
DRUG: Placebo

Sponsor

Mallinckrodt